Inogen (INGN) Income from Non-Controlling Interests (2015 - 2021)
Inogen's (INGN) quarterly Income from Non-Controlling Interests came in at -$2.0 million in Q4 2021, down 345.23% year-over-year from $818813.7 in Q4 2020, and down 434.67% quarter-over-quarter from $600000.0 in Q3 2021.
Powered by 
Analysis
Inogen (INGN) Income from Non-Controlling Interests (2015 - 2021) Analysis & Trends
Inogen (INGN) has reported Income from Non-Controlling Interests for 7 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Income from Non-Controlling Interests fell 345.23% year-over-year to -$2.0 million in Q4 2021; TTM through Dec 2021 was $126000.0, a 125.71% increase from a year earlier, with the FY2025 full-year figure at $546000.0, changed N/A from the prior year.
- Income from Non-Controlling Interests was -$2.0 million for Q4 2021 at Inogen, down from $600000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $1.1 million in Q1 2021 and troughed at -$2.0 million in Q4 2021.
- A 5-year average of -$84750.0 and a median of -$222500.0 in 2017 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests sank 1733.33% in 2017 and soared 423.2% in 2018, its largest moves.
- Over 5 years, Income from Non-Controlling Interests stood at -$125000.0 in 2017, then soared by 423.2% to $404000.0 in 2018, then slumped by 251.49% to -$612000.0 in 2019, then gained by 26.31% to -$451000.0 in 2020, then sank by 345.23% to -$2.0 million in 2021.
- The last three Income from Non-Controlling Interests figures came in at -$2.0 million (Q4 2021), $600000.0 (Q3 2021), and $390000.0 (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 900,000.00 |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | 600,000.00 |
| Jun 30, 2021 | 390,000.00 |
| Mar 31, 2021 | 1.14 Mn |
| Dec 31, 2020 | -451,000.00 |
| Sep 30, 2020 | -295,000.00 |
| Jun 30, 2020 | -417,000.00 |
| Mar 31, 2020 | 673,000.00 |
| Dec 31, 2019 | -612,000.00 |
| Sep 30, 2019 | -420,000.00 |
| Jun 30, 2019 | -618,000.00 |
| Mar 31, 2019 | 260,000.00 |
| Dec 31, 2018 | 404,000.00 |
| Sep 30, 2018 | -252,000.00 |
| Jun 30, 2018 | 723,000.00 |
| Mar 31, 2018 | -249,000.00 |
| Dec 31, 2017 | -125,000.00 |
| Sep 30, 2017 | -196,000.00 |
| Jun 30, 2017 | -300,000.00 |
| Mar 31, 2017 | 54,000.00 |